Sotera Health (NYSE:SHC – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports.
According to Zacks, “Sotera Health Company is a provider of mission-critical end-to-end sterilization solutions and lab testing as well as advisory services for the healthcare industry. The company market through businesses which include Sterigenics(R), Nordion(R) and Nelson Labs(R). Sotera Health Company is Sotera Health Company is based in CLEVELAND. “
Other equities research analysts have also recently issued research reports about the stock. Barclays cut shares of Sotera Health from an “overweight” rating to an “equal weight” rating and set a $24.00 price target on the stock. in a report on Wednesday, March 2nd. Wolfe Research started coverage on shares of Sotera Health in a report on Tuesday, April 5th. They issued an “outperform” rating and a $26.00 target price on the stock. Jefferies Financial Group cut shares of Sotera Health from a “buy” rating to a “hold” rating and dropped their target price for the stock from $34.00 to $22.00 in a report on Thursday, March 3rd. KeyCorp dropped their target price on shares of Sotera Health from $33.00 to $30.00 and set an “overweight” rating on the stock in a report on Wednesday, March 2nd. Finally, The Goldman Sachs Group dropped their target price on shares of Sotera Health from $31.00 to $27.00 and set a “buy” rating on the stock in a report on Monday, March 21st. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $26.57.
Sotera Health (NYSE:SHC – Get Rating) last posted its quarterly earnings results on Tuesday, March 1st. The company reported $0.22 EPS for the quarter, beating the Zacks’ consensus estimate of $0.21 by $0.01. Sotera Health had a net margin of 12.55% and a return on equity of 42.00%. The firm had revenue of $241.25 million for the quarter, compared to analysts’ expectations of $238.90 million. During the same quarter in the prior year, the company posted $0.07 earnings per share. The business’s revenue for the quarter was up 11.3% on a year-over-year basis. Sell-side analysts expect that Sotera Health will post 0.92 earnings per share for the current year.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. raised its position in shares of Sotera Health by 6.6% during the 3rd quarter. BlackRock Inc. now owns 10,791,483 shares of the company’s stock valued at $282,196,000 after purchasing an additional 664,248 shares during the period. Stockbridge Partners LLC increased its holdings in Sotera Health by 5.7% in the 3rd quarter. Stockbridge Partners LLC now owns 9,937,488 shares of the company’s stock valued at $259,865,000 after acquiring an additional 532,903 shares during the last quarter. ArrowMark Colorado Holdings LLC increased its holdings in Sotera Health by 5.3% in the 3rd quarter. ArrowMark Colorado Holdings LLC now owns 2,972,824 shares of the company’s stock valued at $77,739,000 after acquiring an additional 150,724 shares during the last quarter. Victory Capital Management Inc. increased its holdings in Sotera Health by 370.9% in the 4th quarter. Victory Capital Management Inc. now owns 2,514,525 shares of the company’s stock valued at $59,217,000 after acquiring an additional 1,980,563 shares during the last quarter. Finally, Vaughan Nelson Investment Management L.P. increased its holdings in Sotera Health by 9.1% in the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 2,380,666 shares of the company’s stock valued at $56,065,000 after acquiring an additional 199,525 shares during the last quarter. Institutional investors and hedge funds own 87.44% of the company’s stock.
About Sotera Health (Get Rating)
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.
- Get a free copy of the StockNews.com research report on Sotera Health (SHC)
- What’s Next For Starbucks (NASDAQ: SBUX)?
- 3 Earnings Plays With Big Move Potential
- There Are Weeds In The Garden At Scotts Miracle-Gro
- It’s Time For FuboTV to Stand Out in the Sea of Streaming
- 3M Stock is Worth a Look Because of the Company it Keeps
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.